Sepsis Associated Disseminated Intravascular Coagulation (DIC)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Sepsis Associated Disseminated Intravascular Coagulation (DIC) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT07176728

A Study to Assess the Safety and Effects of Different Doses of an Investigational Drug, BAY 3389934, in Healthy Japanese…

This study is designed to evaluate a new investigational drug, BAY 3389934, in healthy Japanese volunteers. The primary purpose is to see how safe the drug is a…

Japan16 participantsStarted 2025-09-22

Treatment: BAY 3389934, Matching Placebo / Diluent

All recent trials (3 shown)

CompletedNot Applicable

NCT06986798

A Study to Learn About the Occurrence of Disseminated Intravascular Coagulation in People With Sepsis and Further Worsen…

This is an exploratory study in which data from people with sepsis (a serious condition in which the body responds to an infection that damages vital organs) ad…

Austria, Belgium150 participantsStarted 2025-01-29

Treatment: Local standard medical care

TerminatedPhase 2

NCT00506519

Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis

The primary objective of the study is to explore the efficacy and safety of ATryn® (antithrombin alfa) for the treatment of disseminated intravascular coagulati…

Location not specified25 participantsStarted 2007-07

Treatment: Antithrombin alfa (INN name), Control (Standard treatment)